A MusD retrotransposon insertion in the mouse Slc6a5 gene causes alterations in neuromuscular junction maturation and behavioral phenotypes

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Bogdanik, Laurent P ^a   Chapman, Harold D ^a   Miers, Kathy E ^a   Serreze, David V ^a   Burgess, Robert W ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; GLYCINE TRANSPORTER 2; GLYCINE TRANSPORTER; SLC6A5 PROTEIN, MOUSE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CAUSAL ATTRIBUTION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; FEMALE; GENE; GENE INSERTION; GROOMING; HOT PLATE TEST; HYPERACTIVITY; LIFESPAN; LOSS OF FUNCTION MUTATION; MAZE TEST; MOTONEURON; MOUSE; MUSCLE SPASM; NEUROMUSCULAR SYNAPSE; NEUROPATHOLOGY; NONHUMAN; ONSET AGE; OPEN FIELD TEST; RETROPOSON; SCHIZOPHRENIA; SLC6A5 GENE; SLEEP TIME; SPONTANEOUS MUTATION; SURVIVAL TIME; SYNAPTIC INHIBITION; SYNAPTOGENESIS; TEMPERATURE SENSITIVITY; TRANSCRIPTION REGULATION; ANIMAL; CHROMOSOME; CHROMOSOME MAP; DBA MOUSE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETICS; HUMAN; MALE; METABOLISM; MOTOR ACTIVITY; MOUSE MUTANT; MUTATION; NERVE CELL INHIBITION; NONOBESE DIABETIC MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; SPINAL CORD; WESTERN BLOTTING;

MUS;

ANIMALS; ANXIETY; BLOTTING, WESTERN; CHROMOSOME MAPPING; CHROMOSOMES, MAMMALIAN; FEMALE; GENETIC ASSOCIATION STUDIES; GLYCINE PLASMA MEMBRANE TRANSPORT PROTEINS; GROOMING; HUMANS; MALE; MAZE LEARNING; MICE; MICE, INBRED DBA; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; MOTOR ACTIVITY; MUTAGENESIS, INSERTIONAL; MUTATION; NEURAL INHIBITION; NEUROMUSCULAR JUNCTION; PSYCHOMOTOR PERFORMANCE; RETROELEMENTS; SPINAL CORD;

EID: 84855822395     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030217     Document Type: Article

References (76)

1. Ornung G, Ottersen OP, Cullheim S, Ulfhake B, (1998) Distribution of glutamate-, glycine- and GABA-immunoreactive nerve terminals on dendrites in the cat spinal motor nucleus. Exp Brain Res 118: 517-532.
2. Rekling JC, Funk GD, Bayliss DA, Dong XW, Feldman JL, (2000) Synaptic control of motoneuronal excitability. Physiol Rev 80: 767-852.
3. Renshaw B, (1946) Central effects of centripetal impulses in axons of spinal ventral roots. J Neurophysiol 9: 191-204.
4. Eccles JC, Fatt P, Koketsu K, (1954) Cholinergic and inhibitory synapses in a pathway from motor-axon collaterals to motoneurones. J Physiol (Lond) 126: 524-562.
5. Alvarez FJ, Dewey DE, McMillin P, Fyffe RE, (1999) Distribution of cholinergic contacts on Renshaw cells in the rat spinal cord: a light microscopic study. J Physiol (Lond 515 (Pt 3): 787-797.
6. Fyffe RE, (1991) Glycine-like immunoreactivity in synaptic boutons of identified inhibitory interneurons in the mammalian spinal cord. Brain Research 547: 163-166 doi:10.1016/0006-8993(91)90590-R.
7. Holstege JC, Bongers CM, (1991) A glycinergic projection from the ventromedial lower brainstem to spinal motoneurons. An ultrastructural double labeling study in rat. Brain Res 566: 308-315.
8. Todd AJ, Sullivan AC, (1990) Light microscope study of the coexistence of GABA-like and glycine-like immunoreactivities in the spinal cord of the rat. J Comp Neurol 296: 496-505 doi:10.1002/cne.902960312.
9. Todd AJ, (2010) Neuronal circuitry for pain processing in the dorsal horn. Nat Rev Neurosci 11: 823-836 doi:10.1038/nrn2947.
10. Beyer C, Roberts LA, Komisaruk BR, (1985) Hyperalgesia induced by altered glycinergic activity at the spinal cord. Life Sci 37: 875-882.
11. Sherman SE, Loomis CW, (1996) Strychnine-sensitive modulation is selective for non-noxious somatosensory input in the spinal cord of the rat. Pain 66: 321-330 doi:10.1016/0304-3959(96)03063-1.
12. Zeilhofer HU, (2005) The glycinergic control of spinal pain processing. Cell Mol Life Sci 62: 2027-2035 doi:10.1007/s00018-005-5107-2.
13. Jursky F, Nelson N, (1995) Localization of glycine neurotransmitter transporter (GLYT2) reveals correlation with the distribution of glycine receptor. J Neurochem 64: 1026-1033.
14. Dugué GP, Dumoulin A, Triller A, Dieudonné S, (2005) Target-dependent use of co-released inhibitory transmitters at central synapses. J Neurosci 25: 6490-6498 doi:10.1523/JNEUROSCI.1500-05.2005.
15. Holopainen I, Kontro P, (1989) Uptake and release of glycine in cerebellar granule cells and astrocytes in primary culture: Potassium-stimulated release from granule cells is calcium-dependent. J Neurosci Res 24: 374-383 doi:10.1002/jnr.490240306.
16. Kemp JA, Leeson PD, (1993) The glycine site of the NMDA receptor - five years on. Trends in Pharmacological Sciences 14: 20-25 doi:10.1016/0165-6147(93)90108-V.
17. Ahmadi S, (2003) Facilitation of Spinal NMDA Receptor Currents by Spillover of Synaptically Released Glycine. Science 300: 2094-2097 doi:10.1126/science.1083970.
18. Betz H, Laube B, (2006) Glycine receptors: recent insights into their structural organization and functional diversity. J Neurochem 97: 1600-1610 doi:10.1111/j.1471-4159.2006.03908.x.
19. Betz H, Gomeza J, Armsen W, Scholze P, Eulenburg V, (2006) Glycine transporters: essential regulators of synaptic transmission. Biochem Soc Trans 34: 55-58 doi:10.1042/BST0340055.
20. Rousseau F, Aubrey KR, Supplisson S, (2008) The Glycine Transporter GlyT2 Controls the Dynamics of Synaptic Vesicle Refilling in Inhibitory Spinal Cord Neurons. Journal of Neuroscience 28: 9755-9768 doi:10.1523/JNEUROSCI.0509-08.2008.
21. Gomeza J, Hülsmann S, Ohno K, Eulenburg V, Szöke K, et al. (2003) Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition. Neuron 40: 785-796.
22. Harvey RJ, (2008) A critical role for glycine transporters in hyperexcitability disorders. Front Mol Neurosci 1 Available: http://www.frontiersin.org/Journal/Abstract.aspx?s=702&name=molecular_neuroscience&ART_DOI=10.3389/neuro.02.001.2008. Accessed 5 July 2011.
23. Gomeza J, Ohno K, Hülsmann S, Armsen W, Eulenburg V, et al. (2003) Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality. Neuron 40: 797-806.
24. Eulenburg V, Becker K, Gomeza J, Schmitt B, Becker C-M, et al. (2006) Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia. Biochem Biophys Res Commun 348: 400-405 doi:10.1016/j.bbrc.2006.07.080.
25. Rees MI, Harvey K, Pearce BR, Chung S-K, Duguid IC, et al. (2006) Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease. Nature Genetics 38: 801-806 doi:10.1038/ng1814.
26. Charlier C, Coppieters W, Rollin F, Desmecht D, Agerholm JS, et al. (2008) Highly effective SNP-based association mapping and management of recessive defects in livestock. Nature Genetics 40: 449-454 doi:10.1038/ng.96.
27. Gill JL, Capper D, Vanbellinghen J-F, Chung S-K, Higgins RJ, et al. (2011) Startle disease in Irish wolfhounds associated with a microdeletion in the glycine transporter GlyT2 gene. Neurobiol Dis 43: 184-189 doi:10.1016/j.nbd.2011.03.010.
28. Feng G, Tintrup H, Kirsch J, Nichol MC, Kuhse J, et al. (1998) Dual requirement for gephyrin in glycine receptor clustering and molybdoenzyme activity. Science 282: 1321-1324.
29. Reiss J, Gross-Hardt S, Christensen E, Schmidt P, Mendel RR, et al. (2001) A mutation in the gene for the neurotransmitter receptor-clustering protein gephyrin causes a novel form of molybdenum cofactor deficiency. Am J Hum Genet 68: 208-213 doi:10.1086/316941.
30. Rees MI, Harvey K, Ward H, White JH, Evans L, et al. (2003) Isoform heterogeneity of the human gephyrin gene (GPHN), binding domains to the glycine receptor, and mutation analysis in hyperekplexia. J Biol Chem 278: 24688-24696 doi:10.1074/jbc.M301070200.
31. Harvey RJ, (2004) GlyR 3: An Essential Target for Spinal PGE2-Mediated Inflammatory Pain Sensitization. Science 304: 884-887 doi:10.1126/science.1094925.
32. Xiong W, Cheng K, Cui T, Godlewski G, Rice KC, et al. (2011) Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia. Nature Chemical Biology 7: 296-303 doi:10.1038/nchembio.552.
33. McCool BA, Chappell A, (2007) Strychnine and taurine modulation of amygdala-associated anxiety-like behavior is "state" dependent. Behav Brain Res 178: 70-81 doi:10.1016/j.bbr.2006.12.002.
34. Tsai GE, Ralph-Williams RJ, Martina M, Bergeron R, Berger-Sweeney J, et al. (2004) Gene knockout of glycine transporter 1: characterization of the behavioral phenotype. Proc Natl Acad Sci USA 101: 8485-8490 doi:10.1073/pnas.0402662101.
35. Yee BK, Balic E, Singer P, Schwerdel C, Grampp T, et al. (2006) Disruption of glycine transporter 1 restricted to forebrain neurons is associated with a procognitive and antipsychotic phenotypic profile. J Neurosci 26: 3169-3181 doi:10.1523/JNEUROSCI.5120-05.2006.
36. Jamra RA, Villela AW, Klein K, Becker T, Schulze TG, et al. (2006) No association between genetic variants at the GLYT2 gene and bipolar affective disorder and schizophrenia. Psychiatr Genet 16: 91 doi:10.1097/01.ypg.0000199450.07786.ab.
37. Deng X, Sagata N, Takeuchi N, Tanaka M, Ninomiya H, et al. (2008) Association study of polymorphisms in the neutral amino acid transporter genes SLC1A4, SLC1A5 and the glycine transporter genes SLC6A5, SLC6A9 with schizophrenia. BMC Psychiatry 8: 58 doi:10.1186/1471-244X-8-58.
38. Rodgers RJ, Howard K, Stewart S, Waring P, Wright FL, (2010) Anxioselective profile of glycineB receptor partial agonist, D-cycloserine, in plus-maze-naïve but not plus-maze-experienced mice. Eur J Pharmacol 646: 31-37 doi:10.1016/j.ejphar.2010.08.005.
39. Mager DL, Freeman JD, (2000) Novel mouse type D endogenous proviruses and ETn elements share long terminal repeat and internal sequences. J Virol 74: 7221-7229.
40. Zafra F, Aragón C, Olivares L, Danbolt NC, Giménez C, et al. (1995) Glycine transporters are differentially expressed among CNS cells. J Neurosci 15: 3952-3969.
41. Zeilhofer HU, Studler B, Arabadzisz D, Schweizer C, Ahmadi S, et al. (2005) Glycinergic neurons expressing enhanced green fluorescent protein in bacterial artificial chromosome transgenic mice. J Comp Neurol 482: 123-141 doi:10.1002/cne.20349.
42. Jansen JK, Fladby T, (1990) The perinatal reorganization of the innervation of skeletal muscle in mammals. Prog Neurobiol 34: 39-90.
43. O'Brien RA, Ostberg AJ, Vrbová G, (1978) Observations on the elimination of polyneuronal innervation in developing mammalian skeletal muscle. J Physiol (Lond) 282: 571-582.
44. Personius KE, Balice-Gordon RJ, (2000) Activity-dependent editing of neuromuscular synaptic connections. Brain Res Bull 53: 513-522.
45. Mishina M, Takai T, Imoto K, Noda M, Takahashi T, et al. (1986) Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature 321: 406-411 doi:10.1038/321406a0.
46. Witzemann V, Barg B, Nishikawa Y, Sakmann B, Numa S, (1987) Differential regulation of muscle acetylcholine receptor gamma- and epsilon-subunit mRNAs. FEBS Lett 223: 104-112.
47. Gu Y, Hall ZW, (1988) Immunological evidence for a change in subunits of the acetylcholine receptor in developing and denervated rat muscle. Neuron 1: 117-125.
48. Missias AC, Mudd J, Cunningham JM, Steinbach JH, Merlie JP, et al. (1997) Deficient development and maintenance of postsynaptic specializations in mutant mice lacking an "adult" acetylcholine receptor subunit. Development 124: 5075-5086.
49. Missias AC, Chu GC, Klocke BJ, Sanes JR, Merlie JP, (1996) Maturation of the acetylcholine receptor in skeletal muscle: regulation of the AChR gamma-to-epsilon switch. Dev Biol 179: 223-238 doi:10.1006/dbio.1996.0253.
50. Martinou JC, Merlie JP, (1991) Nerve-dependent modulation of acetylcholine receptor epsilon-subunit gene expression. J Neurosci 11: 1291-1299.
51. Prody CA, Merlie JP, (1991) A developmental and tissue-specific enhancer in the mouse skeletal muscle acetylcholine receptor alpha-subunit gene regulated by myogenic factors. J Biol Chem 266: 22588-22596.
52. Numberger M, Dürr I, Kues W, Koenen M, Witzemann V, (1991) Different mechanisms regulate muscle-specific AChR gamma- and epsilon-subunit gene expression. EMBO J 10: 2957-2964.
53. Eftimie R, Brenner HR, Buonanno A, (1991) Myogenin and MyoD join a family of skeletal muscle genes regulated by electrical activity. Proc Natl Acad Sci USA 88: 1349-1353.
54. Witzemann V, Sakmann B, (1991) Differential regulation of MyoD and myogenin mRNA levels by nerve induced muscle activity. FEBS Lett 282: 259-264.
55. Eftimie R, Brenner HR, Buonanno A, (1991) Myogenin and MyoD join a family of skeletal muscle genes regulated by electrical activity. Proc Natl Acad Sci USA 88: 1349-1353.
56. Duclert A, Piette J, Changeux JP, (1991) Influence of innervation of myogenic factors and acetylcholine receptor alpha-subunit mRNAs. Neuroreport 2: 25-28.
57. Neville CM, Schmidt M, Schmidt J, (1992) Response of myogenic determination factors to cessation and resumption of electrical activity in skeletal muscle: a possible role for myogenin in denervation supersensitivity. Cell Mol Neurobiol 12: 511-527.
58. Haranishi Y, Hara K, Terada T, Nakamura S, Sata T, (2010) The antinociceptive effect of intrathecal administration of glycine transporter-2 inhibitor ALX1393 in a rat acute pain model. Anesth Analg 110: 615-621 doi:10.1213/ANE.0b013e3181c7ebbb.
59. Steele AD, Jackson WS, King OD, Lindquist S, (2007) The power of automated high-resolution behavior analysis revealed by its application to mouse models of Huntington's and prion diseases. Proceedings of the National Academy of Sciences 104: 1983-1988 doi:10.1073/pnas.0610779104.
60. Kalueff A, (2009) Experimental animal models in neurobehavioral research. New York Nova Science Publishers.
61. Martinowich K, Schloesser RJ, Jimenez DV, Weinberger DR, Lu B, (2011) Activity-dependent brain-derived neurotrophic factor expression regulates cortistatin-interneurons and sleep behavior. Mol Brain 4: 11 doi:10.1186/1756-6606-4-11.
62. Prut L, (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. European Journal of Pharmacology 463: 3-33 doi:10.1016/S0014-2999(03)01272-X.
63. Kano H, Kurahashi H, Toda T, (2007) Genetically regulated epigenetic transcriptional activation of retrotransposon insertion confers mouse dactylaplasia phenotype. Proc Natl Acad Sci USA 104: 19034-19039 doi:10.1073/pnas.0705483104.
64. Ribet D, (2004) An active murine transposon family pair: Retrotransposition of "master" MusD copies and ETn trans-mobilization. Genome Research 14: 2261-2267 doi:10.1101/gr.2924904.
65. Budnik V, Zhong Y, Wu CF, (1990) Morphological plasticity of motor axons in Drosophila mutants with altered excitability. J Neurosci 10: 3754-3768.
66. Schuster CM, Davis GW, Fetter RD, Goodman CS, (1996) Genetic dissection of structural and functional components of synaptic plasticity. II. Fasciclin II controls presynaptic structural plasticity. Neuron 17: 655-667.
67. Mosca TJ, Carrillo RA, White BH, Keshishian H, (2005) Dissection of synaptic excitability phenotypes by using a dominant-negative Shaker K+ channel subunit. Proc Natl Acad Sci USA 102: 3477-3482 doi:10.1073/pnas.0406164102.
68. Bradaia A, (2004) Role of glial and neuronal glycine transporters in the control of glycinergic and glutamatergic synaptic transmission in lamina X of the rat spinal cord. The Journal of Physiology 559: 169-186 doi:10.1113/jphysiol.2004.068858.
69. Mohn AR, Gainetdinov RR, Caron MG, Koller BH, (1999) Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia. Cell 98: 427-436 doi:10.1016/S0092-8674(00)81972-8.
70. Ballard TM, Pauly-Evers M, Higgins GA, Ouagazzal A-M, Mutel V, et al. (2002) Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivity. J Neurosci 22: 6713-6723 doi:20026610.
71. Basu AC, Tsai GE, Ma C-L, Ehmsen JT, Mustafa AK, et al. (2008) Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior. Mol Psychiatry 14: 719-727 doi:10.1038/mp.2008.130.
72. Dawe GS, Hwang EH, Tan CH, (2009) Pathophysiology and animal models of schizophrenia. Ann Acad Med Singap 38: 425-426.
73. Labrie V, Roder JC, (2010) The involvement of the NMDA receptor d-serine/glycine site in the pathophysiology and treatment of schizophrenia. Neuroscience & Biobehavioral Reviews 34: 351-372 doi:10.1016/j.neubiorev.2009.08.002.
74. Monti JM, Monti D, (2004) Sleep in schizophrenia patients and the effects of antipsychotic drugs. Sleep Medicine Reviews 8: 133-148 doi:10.1016/S1087-0792(02)00158-2.
75. Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, et al. (2000) Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28: 41-51.
76. Spandidos A, Wang X, Wang H, Seed B, (2009) PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Research 38: D792-D799 doi:10.1093/nar/gkp1005.